Vitamin D in the healthy and inflamed central nervous system: Access and function

Journal of the Neurological Sciences

Volumn 311, Issue 1-2, 2011, Pages 37-43

  Smolders, Joost ^a,b   Moen, Stine Marit ^c   Damoiseaux, Jan ^b   Huitinga, Inge ^d   Holmøy, Trygve ^e,f  

^a Division of Clinical and Experimental Immunology   (Netherlands)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

^d NETHERLANDS INSTITUTE FOR NEUROSCIENCE   (Netherlands)

^e UNIVERSITY OF OSLO   (Norway)

^f AKERSHUS UNIVERSITY HOSPITAL   (Norway)

Author keywords

25 hydroxyvitamin D; Central nervous system; Multiple sclerosis; Vitamin D; Vitamin D binding protein

Indexed keywords

1,25 DIHYDROXYERGOCALCIFEROL; 25 HYDROXYVITAMIN D; CYP27B1 PROTEIN; OXYGENASE; UNCLASSIFIED DRUG; VITAMIN D; VITAMIN D BINDING PROTEIN; VITAMIN D RECEPTOR;

CENTRAL NERVOUS SYSTEM; DEMYELINATION; ENCEPHALITIS; HUMAN; IMMUNOMODULATION; INFLAMMATION; LYMPHOCYTE; NERVE FIBER DEGENERATION; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REMYELINIZATION; REVIEW; TRANSPORT KINETICS; VITAMIN METABOLISM;

EID: 81255135921     PISSN: 0022510X     EISSN: 18785883     Source Type: Journal    
DOI: 10.1016/j.jns.2011.07.033     Document Type: Article

References (110)

1. A. Ascherio, K.L. Munger, and K.C. Simon Vitamin D and multiple sclerosis Lancet Neurol 9 2010 599 612
2. S. Simpson, B. Taylor, L. Blizzard, A.L. Ponsonby, F. Pittas, and H. Tremlett Higher 25-hydroxyvitamin D is associated with lower relapse risk in multiple sclerosis Ann Neurol 68 2010 193 203
3. I. van der Mei, A. Ponsonby, T. Dwyer, L. Blizzard, B.V. Taylor, and T. Kilpatrick Vitamin D levels in people with multiple sclerosis and community controls in Tasmania, Australia J Neurol 254 2007 581 590 (Pubitemid 46781963)
4. J. Smolders, P. Menheere, A. Kessels, J. Damoiseaux, and R. Hupperts Association of vitamin D metabolite levels with relapse rate and disability in multiple sclerosis Mult Scler 14 2008 1220 1224
5. B. Weinstock-Guttman, R. Zivadinov, J. Qu, D. Cookfair, X. Duan, and E. Bang Vitamin D metabolites are associated with clinical and MRI outcomes in multiple sclerosis patients J Neurol Neurosurg Psychiatry 82 2011 189 195
6. D.M. Provvedini, C.D. Tsoukas, L.J. Deftos, and S.C. Manolagas 1,25-dihydroxyvitamin D3 receptors in human leukocytes Science 221 1983 1181 1183
7. C.D. Tsoukas, D.M. Provvedini, and S.C. Manolagas 1,25-dihydroxyvitamin D3: a novel immunoregulatory hormone Science 224 1984 1438 1440
8. J.M. Lemire, and D.C. Archer 1,25-dihydroxyvitamin D3 prevents the in vivo induction of murine experimental autoimmune encephalomyelitis J Clin Invest 87 1991 1103 1107
9. S.V. Ramagopalan, N. Maugeri, L. Handunnetthi, M.R. Lincoln, S.M. Orton, and D.A. Dyment Expression of the multiple sclerosis-associated MHC class II Allele HLA-DRB1*1501 is regulated by vitamin D PLoS Genet 5 2009 e1000369
10. L.E. Jeffery, F. Burke, M. Mura, Y. Zheng, O.S. Qureshi, and M. Hewison 1,25-Dihydroxyvitamin D3 and IL-2 combine to inhibit T cell production of inflammatory cytokines and promote development of regulatory T cells expressing CTLA-4 and FoxP3 J Immunol 183 2009 5458 5467
11. J. Correale, M.C. Ysrraelit, and M.I. Gaitan Immunomodulatory effects of Vitamin D in multiple sclerosis Brain 132 2009 1146 1160
12. C.E. Hayes, M.T. Cantorna, and H.F. DeLuca Vitamin D and multiple sclerosis Proc Soc Exp Biol Med 216 1997 21 27
13. J. Smolders, M. Thewissen, E. Peelen, P. Menheere, J.W. Cohen Tervaert, and J. Damoiseaux Regulatory T cell function correlates with serum 25-hydroxyvitamin D, but not with 1,25-dihydroxyvitamin D, parathyroid hormone and calcium levels in patients with relapsing remitting multiple sclerosis J Steroid Biochem Mol Biol 121 2010 243 246
14. J. Smolders, P. Menheere, M. Thewissen, E. Peelen, J.W. Cohen Tervaert, and R. Hupperts Vitamin D status is positively correlated with regulatory T cell function in patients with multiple sclerosis PLoS One 4 2009 e6635
15. D.A. Fernandes de Abreu, D. Eyles, and F. Feron Vitamin D, a neuro-immunomodulator: implications for neurodegenerative and autoimmune diseases Psychoneuroendocrinology 34 S1 2009 S265 S277
16. J.F. McLeod, and N.E. Cooke The vitamin D-binding protein, alpha-fetoprotein, albumin multigene family: detection of transcripts in multiple tissues J Biol Chem 264 1989 21760 21769 (Pubitemid 20028745)
17. D. Dumont, J.P. Noben, J. Raus, P. Stinissen, and J. Robben Proteomic analysis of cerebrospinal fluid from multiple sclerosis patients Proteomics 4 2004 2117 2124 (Pubitemid 38880377)
18. B.N. Hammack, K.Y. Fung, S.W. Hunsucker, M.W. Duncan, M.P. Burgoon, and G.P. Owens Proteomic analysis of multiple sclerosis cerebrospinal fluid Mult Scler 10 2004 245 260 (Pubitemid 38807450)
19. Z. Qin, Y. Qin, and S. Liu Alteration of DBP levels in CSF of patients with MS by proteomics analysis Cell Mol Neurobiol 29 2009 203 210
20. S. D'Aguanno, D. Franciotta, S. Lupisella, A. Barassi, D. Pieragostino, and A. Lugaresi Protein profiling of Guillain-Barrè syndrome cerebrospinal fluid by two-dimensional electrophoresis and mass spectrometry Neurosci Lett 485 2010 49 54
21. J. Zhang, I. Sokal, E.R. Peskind, J.F. Quinn, J. Jankovic, and C. Kenney CSF multianalyte profile distinguishes Alzheimer and Parkinson diseases Am J Clin Pathol 129 2008 526 529 (Pubitemid 352029270)
22. N.E. Cooke, and E.V. David Serum vitamin D-binding protein is a third member of the albumin and alpha fetoprotein gene family J Clin Invest 76 1985 2420 2424 (Pubitemid 16155542)
23. W.M. Pardridge, R. Sakiyama, and W.A. Coty Restricted transport of vitamin D and A derivatives through the rat blood-brain barrier J Neurochem 44 1985 1138 1141 (Pubitemid 15105766)
24. S. Balabanova, H.P. Richter, G. Antoniadis, J. Homoki, N. Kremmer, and J. Hanle 25-Hydroxyvitamin D, 24, 25-dihydroxyvitamin D and 1,25-dihydroxyvitamin D in human cerebrospinal fluid Klin Wochenschr 62 1984 1086 1090 (Pubitemid 15202112)
25. T. Holmøy, S.M. Moen, T.A. Gundersen, M.F. Holick, E. Fainardi, and M. Castellazzi 25-hydroxyvitamin D in cerebrospinal fluid during relapse and remission of multiple sclerosis Mult Scler 15 2009 1280 1285
26. M.F. Holick, and D. Vitamin Status: Measurement, Interpretation, and Clinical Application Ann Epidemiol 19 2008 73 78
27. C.M. Mendel The free hormone hypothesis: a physiologically based mathematical model Endocr Rev 10 1989 232 274 (Pubitemid 19223060)
28. P. White, and N. Cooke The multifunctional properties and characteristics of vitamin D-binding protein Trends Endocrinol Metab 8 2000 320 327
29. T. Holmøy, and S.M. Moen Assessing vitamin D in the central nervous system Acta Neurol Scand Suppl 190 2010 88 92
30. A. Nykjaer, D. Dragun, D. Walther, H. Vorum, C. Jacobsen, and J. Herz An endocytic pathway essential for renal uptake and activation of the steroid 25-(OH) vitamin D3 Cell 96 1999 507 515 (Pubitemid 29106838)
31. A. Nykjaer, J.C. Fyfe, R. Kozyraki, J.R. Leheste, C. Jacobsen, and M.S. Nielsen Cubilin dysfunction causes abnormal metabolism of the steroid hormone 25(OH) vitamin D(3) Proc Natl Acad Sci USA 98 2001 13895 13900 (Pubitemid 33115995)
32. G. Zheng, D.R. Bachinsky, I. Stamenkovic, D.K. Strickland, D. Brown, and G. Andres Organ distribution in rats of two members of the low-density lipoprotein receptor gene family, gp330 and LRP/alpha 2MR, and the receptor-associated protein (RAP) J Histochem Cytochem 42 1994 531 542 (Pubitemid 24090013)
33. W. Pan, A.J. Kastin, T.C. Zankel, P. van Kerkhof, T. Terasaki, and G. Bu Efficient transfer of receptor-associated protein (RAP) across the blood-brain barrier J Cell Sci 117 2004 5071 5078 (Pubitemid 39517522)
34. B.V. Zlokovic, C.L. Martel, E. Matsubara, J.G. McComb, G. Zheng, and R.T. McCluskey Glycoprotein 330/megalin: probable role in receptor-mediated transport of apolipoprotein J alone and in a complex with Alzheimer disease amyloid beta at the blood-brain and blood-cerebrospinal fluid barriers Proc Natl Acad Sci USA 93 1996 4229 4234
35. W.E. Stumpf, H.J. Bidmon, L. Li, C. Pilgrim, A. Bartke, and A. Mayerhofer Nuclear receptor sites for vitamin D-soltriol in midbrain and hindbrain of Siberian hamster (Phodopus sungorus) assessed by autoradiography Histochemistry 98 1992 155 164
36. M.R. Walters, C.T. Fischette, C. Fetzer, B. May, P.C. Riggle, and M. Tibaldo-Bongiorno Specific 1,25-dihydroxyvitamin D3 binding sites in choroid plexus Eur J Pharmacol 24 1992 309 311
37. G. Disanto, S.V. Ramagopalan, A.E. Para, and L. Handunnetthi The emerging role of vitamin D binding protein in multiple sclerosis J Neurol 258 2010 353 358
38. M. Comabella, M. Fernández, R. Martin, S. Rivera-Vallvé, E. Borrás, and C. Chiva Cerebrospinal fluid chitinase 3-like 1 levels are associated with conversion to multiple sclerosis Brain 133 2010 1082 1093
39. D. Chiasserini, M. Di Filippo, A. Candeliere, F. Susta, P.L. Orvietani, and P. Calabresi CSF proteome analysis in multiple sclerosis patients by two-dimensional electrophoresis Eur J Neurol 15 2008 998 1001
40. M.P. Stoop, L.J. Dekker, M.K. Titulaer, R.J. Lamers, P.C. Burgers, and P.A. Sillevis Smitt Quantitative matrix-assisted laser desorption ionization-fourier transform ion cyclotron resonance (MALDI-FT-ICR) peptide profiling and identification of multiple-sclerosis-related proteins J Proteome Res 8 2009 1404 1414
41. H. Tumani, V. Lehmensiek, D. Rau, I. Guttmann, G. Tauscher, and H. Mogel CSF proteome analysis in clinically isolated syndrome (CIS): candidate markers for conversion to definite multiple sclerosis Neurosci Lett 452 2009 214 217
42. J. Ottervald, B. Franzén, K. Nilsson, L.I. Andersson, M. Khademi, and B. Eriksson Multiple sclerosis: Identification and clinical evaluation of novel CSF biomarkers J Proteomics 73 2010 1117 1132
43. M.P. Stoop, V. Singh, L.J. Dekker, M.K. Titulaer, C. Stingl, and P.C. Burgers Proteomics comparison of cerebrospinal fluid of relapsing remitting and primary progressive multiple sclerosis PLoS One 5 2010 e12442
44. T.D. Veenstra, K. Prüfer, C. Koenigsberger, S.W. Brimjoin, J.P. Grande, and R. Kumar 1,25-dihydroxyvitamin D receptors in the central nervous system of the rat embryo Brain Res 804 1998 193 205 (Pubitemid 28496623)
45. K. Prüfer, T.D. Veenstra, G.F. Jirikowski, and R. Kumar Distribution of 1,25-dihydroxyvitamin D3 receptor immunoreactivity in the rat brain and spinal cord J Chem Neuroanat 16 1999 135 145 (Pubitemid 29155499)
46. D.W. Eyles, S. Smith, R. Kinobe, M. Hewison, and J.J. McGrath Distribution of the Vitamin D receptor and 1α-hydroxylase in human brain J Chem Neuroanat 29 2005 21 30 (Pubitemid 39602785)
47. 3-1α- hydroxylase J Clin Endocrinol Metab 86 2001 888 894
48. D. Eyles, J. Brown, A. Mackay-Sim, J. McGrath, and F. Feron Vitamin D3 and brain development Neuroscience 118 2003 641 653
49. F. Feron, T.H. Burne, J. Brown, E. Smith, J.J. McGrath, and A. Mackay-Sim Developmental Vitamin D3 deficiency alters the adult rat brain Brain Res Bull 65 2005 141 148 (Pubitemid 40348799)
50. T.H. Burne, A. Becker, J. Brown, D.W. Eyles, A. Mackay-Sim, and J.J. McGrath Transient prenatal Vitamin D deficiency is associated with hyperlocomotion in adult rats Behav Brain Res 154 2004 549 555 (Pubitemid 39094006)
51. A. Becker, D.W. Eyles, J.J. McGrath, and G. Grecksch Transient prenatal vitamin D deficiency is associated with subtle alterations in learning and memory functions in adult rats Behav Brain Res 161 2005 306 312 (Pubitemid 40732414)
52. A. Tenenhouse, M. Warner, and J.W. Commisiong Neurotransmitters in the CNS of the vitamin D deficient, hypocalcaemic rat Neurochem Int 18 1991 249 255
53. I. Neveu, P. Naveilhan, C. Menaa, D. Wion, P. Brachet, and M. Garabédian Synthesis of 1,25-dihydroxyvitamin D3 by rat brain macrophages in vitro J Neurosci Res 38 1994 214 220 (Pubitemid 24155738)
54. P. Naveilhan, I. Neveu, C. Baudet, K.Y. Ohyama, P. Brachet, and D. Wion Expression of 25(OH) vitamin D3 24-hydroxylase gene in glial cells Neuroreport 5 1993 255 257 (Pubitemid 24026247)
55. K.M. Spach, and C.E. Hayes Vitamin D3 confers protection from autoimmune encephalomyelitis only in female mice J Immunol 175 2005 4119 4126 (Pubitemid 41292076)
56. M. Soilu-Hänninen, L. Airas, I. Mononen, A. Heikkilä, M. Viljanen, and A. Hänninen 25-Hydroxyvitamin D levels in serum at the onset of multiple sclerosis Mult Scler 11 2005 266 271 (Pubitemid 40775180)
57. M. Soilu-Hanninen, M. Laaksonen, I. Laitinen, J.P. Eralinna, E.M. Lilius, and I. Mononen A longitudinal study of serum 25-hydroxyvitamin D and intact PTH levels indicate the importance of vitamin D and calcium homeostasis regulation in multiple sclerosis J Neurol Neurosurg Psychiatry 79 2008 152 157 (Pubitemid 351236545)
58. S. Simpson, B. Taylor, L. Blizzard, A.L. Ponsonby, F. Pittas, and H. Tremlett Higher 25-hydroxyvitamin D is associated with lower relapse risk in MS Ann Neurol 68 2010 193 203
59. E.M. Mowry, L.B. Krupp, M. Milazzo, D. Chabas, J.B. Strober, and A.L. Belman Vitamin D status is associated with relapse rate in pediatric-onset multiple sclerosis Ann Neurol 67 2010 618 624
60. M.T. Cantorna, C.E. Hayes, and H.F. DeLuca 1,25-Dihydroxyvitamin D3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis Proc Natl Acad Sci USA 93 1996 7861 7864 (Pubitemid 26277129)
61. A.F. Embry, L.R. Snowdon, and R. Vieth Vitamin D and seasonal fluctuations of gadolinium-enhancing magnetic resonance imaging lesions in multiple sclerosis Ann Neurol 48 2000 271 272 (Pubitemid 30617053)
62. J. Killestein, M.H. Rep, J.F. Meilof, H.J. Ader, B.M. Uitdehaag, and F. Barkhof Seasonal variation in immune measurements and MRI markers of disease activity in MS Neurology 58 2002 1077 1080 (Pubitemid 34298549)
63. S.M. Kimball, M.R. Ursell, P. O'Connor, and R. Vieth Safety of vitamin D3 in adults with multiple sclerosis Am J Clin Nutr 86 2007 645 651 (Pubitemid 47435831)
64. S. Vukicevic, I. Kracun, Z. Vukelic, B. Krempien, H. Rosner, and C. Cosovic 24R,25-dihydroxyvitamin D3 prevents aluminum-induced alteration of brain gangliosides in uremic rats by keeping the metal within perivascular astrocytes of the blood-brain barrier Neurochem Int 20 1992 391 399
65. G. Penna, and L. Adorini 1 Alpha,25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation J Immunol 164 2000 2405 2411 (Pubitemid 30115468)
66. E. Garcion, L. Sindji, S. Nataf, P. Brachet, F. Darcy, and C.N. Montero-Menei Treatment of experimental autoimmune encephalomyelitis in rat by 1,25-dihydroxyvitamin D3 leads to early effects within the central nervous system Acta Neuropathol 105 2003 438 448 (Pubitemid 36798839)
67. M. Moore, A. Piazza, Y. Nolan, and M.A. Lynch Treatment with dexamethasone and vitamin D3 attenuates neuroinflammatory age-related changes in rat hippocampus Synapse 61 2007 851 861 (Pubitemid 47328804)
68. J. Smolders, and J. Damoiseaux Vitamin D as a T cell modulator in multiple sclerosis Vitam Horm 86 2011 401 428
69. A.P. Lysandropoulos, E. Jaquiéry, S. Jilek, G. Pantaleo, M. Schluep, and R.A. Du Pasquier Vitamin D has a direct immunomodulatory effect on CD8+ T cells of patients with early multiple sclerosis and healthy control subjects J Neuroimmunol 233 2010 240 244
70. C.G. Mayne, J.A. Spanier, L.M. Relland, C.B. Williams, and C.E. Hayes 1,25-Dihydroxyvitamin D(3) acts directly on the T lymphocyte vitamin D receptor to inhibit experimental autoimmune encephalomyelitis Eur J Immunol Jan. 4 2011 10.1002/eji.201040632 [published online]
71. G. Heine, U. Niesner, H.D. Chang, A. Steinmeyer, U. Zügel, and T. Zuberbier 1,25-dihydroxyvitamin D(3) promotes IL-10 production in human B cells Eur J Immunol 38 2008 2210 2218
72. M.T. Cantorna, W.D. Woodward, C.E. Hayes, and H.F. DeLuca 1,25-dihydroxyvitamin D3 is a positive regulator for the two anti-encephalitogenic cytokines TGF-beta 1 and IL-4 J Immunol 160 1998 5314 5319 (Pubitemid 28267819)
73. C. Lefebvre d' Hellencourt, C.N. Montero-Menei, R. Bernard, and D. Couez Vitamin D3 inhibits proinflammatory cytokines and nitric oxide production by the EOC13 microglial cell line J Neurosci Res 71 2003 575 582 (Pubitemid 36158342)
74. I. Furman, C. Baudet, and P. Brachet Differential expression of M-CSF, LIF, and TNF-alpha genes in normal and malignant rat glial cells: regulation by lipopolysaccharide and vitamin D J Neurosci Res 46 1996 360 366 (Pubitemid 26376370)
75. L.J. Dickie, L.D. Church, L.R. Coulthard, R.J. Mathews, P. Emery, and M.F. McDermott Vitamin D3 down-regulates intracellular Toll-like receptor 9 expression and Toll-like receptor 9-induced IL-6 production in human monocytes Rheumatology 49 2010 1466 1471
76. Z. Urry Ligation of TLR9 induced on IL-10-secreting Tregs by 1α,25-dihydroxyvitamin D3 abbrogates regulatory function J Clin Invest 119 2009 387 398
77. E.A. Kabat, M. Glusman, and V. Knaub Quantitative estimation of the albumin and gamma globulin in normal and pathologic cerebrospinal fluid by immunochemical methods Am J Med 4 1948 653 662
78. Y. Qin, P. Duquette, Y. Zhang, P. Talbot, R. Poole, and J. Antel Clonal expansion and somatic hypermutation of V(H) genes of B cells from cerebrospinal fluid in multiple sclerosis J Clin Invest 102 1998 1045 1050 (Pubitemid 28419250)
79. B. Serafini, B. Rosicarelli, R. Magliozzi, E. Stigliano, and F. Aloisi Detection of ectopic B-cell follicles with germinal centers in the meninges of patients with secondary progressive multiple sclerosis Brain Pathol 14 2004 164 174 (Pubitemid 38656388)
80. S. Chen, G.P. Sims, X.X. Chen, Y.Y. Gu, S. Chen, and P.E. Lipsky Modulatory effects of 1,25-dihydroxyvitamin D3 on human B cell differentiation J Immunol 179 2007 1634 1647
81. W.C. Chen, B. Vayuvegula, and S. Gupta 1,25-Dihydroxyvitamin D3-mediated inhibition of human B cell differentiation Clin Exp Immunol 69 1987 639 646 (Pubitemid 17125569)
82. S. Iho, T. Takahashi, F. Kura, H. Sugiyama, and T. Hoshino The effect of 1,25-dihydroxyvitamin D3 on in vitro immunoglobulin production in human B cells J Immunol 136 1986 4427 4431 (Pubitemid 16090656)
83. J.M. Lemire, J.S. Adams, R. Sakai, and S.C. Jordan 1 alpha,25- dihydroxyvitamin D3 suppresses proliferation and immunoglobulin production by normal human peripheral blood mononuclear cells J Clin Invest 74 1984 657 661 (Pubitemid 14054016)
84. M.H. Vogt, J. ten Kate, R.J. Drent, C.H. Polman, and R. Hupperts Increased osteopontin plasma levels in multiple sclerosis patients correlate with bone-specific markers Mult Scler 16 2010 443 449
85. R. Binder, A. Kress, G. Kan, K. Herrmann, and M. Kirschfink Neutrophil priming by cytokines and Vitamin D binding protein (Gc-globulin): impact on C5a-mediated chemotaxis, degranulation and respiratory burst Mol Immunol 36 1999 885 892 (Pubitemid 30100841)
86. A.B. Shah, S.J. DiMartino, G. Trujillo, and R.R. Kew Selective inhibition of the C5a chemotactic cofactor function of the Vitamin D binding protein by 1,25(OH)2 vitamin D3 Mol Immunol 43 2006 1109 1115 (Pubitemid 43063165)
87. S. Wergeland, O. Torkildsen, K.M. Myhr, L. Aksnes, S. Mork, and L. Bo Dietary vitamin D3 supplements reduces demyelination in the cuprizone model Mult Scler 16 2010 S10
88. M. Goudarzvand, M. Javan, J. Mirnajafi-Zadeh, S. Mozafari, and T. Tiraihi Vitamins E and D3 attenuate demyelination and potentiate remyelination processes of hippocampal formation of rats following local injection of ethidium bromide Cell Mol Neurobiol 30 2010 289 299
89. E. Garcion, S. Nataf, A. Berod, F. Darcy, and P. Prachet 1,25-dihydroxyvitamin D3 inhibits the expression of inducible nitric oxide synthase in rat central nervous system during experimental allergic encephalomyelitis Mol Brain Res 45 1997 255 267 (Pubitemid 27170702)
90. D.J. Llewellyn, I.A. Lang, K.M. Langa, G. Muniz-Terrera, C.L. Phillips, and A. Cherubini Vitamin D and risk of cognitive decline in elderly persons Arch Intern Med 170 2010 1135 1141
91. M.K. Sutherland, M.J. Somerville, L.K.K. Yoong, C. Bergeron, M.R. Haussler, and D.R. Crapper McLachlan Reduction of vitamin D hormone receptor mRNA levels in Alzheimer as compared to Huntington hippocampus: correlation with calcibindin-28 k mRNA levels Mol Brain Res 13 1992 239 250
92. Dursun E, Gezen-Ak D, Yilmazer S. A novel perspective for Alzheimer's disease: vitamin D receptor suppression by Amyloid-β and preventing the Amyloid-β induced alterations by vitamin D in cortical neurons. J Alzheimer Dis 2011;23:207-19.
93. A. Masoumi, B. Goldenson, S. Ghirmai, H. Avagyan, J. Zaghi, and K. Abel 1alpha,25-dihydroxyvitamin D3 interacts with curcuminoids to stimulate amyloid-beta clearance by macrophages of Alzheimer's disease patients J Alzheimers Dis 17 2009 703 717
94. L.D. Brewer, V. Thibault, K.C. Chen, M.C. Langub, P.W. Landfield, and N.M. Porter Vitamin D hormone confers neuroprotection in parallel with downregulation of L-type calcium channel expression in hippocampal neurons J Neurosci 21 2001 98 108 (Pubitemid 32098731)
95. P. Knekt, A. Klikkinen, H. Rissanen, J. Marniemi, K. Sää ksjärvi, and M. Heilövaara Serum vitamin D and the risk of Parkinson disease Arch Neurol 67 2010 808 811
96. J.Y. Wang, J.N. Wu, T.L. Cherng, B.J. Hoffer, H.H. Chen, and C.V. Borlongan Vitamin D(3) attenuates 6-hydroxydopamine-induced neurotoxicity in rats Brain Res 904 2001 67 75 (Pubitemid 32545355)
97. E. Garcion, L. Sindji, C. Montero-Menei, C. Andre, P. Brachet, and F. Darcy Expression of inducible nitric oxide synthase during rat brain inflammation: regulation by 1,25-dihydroxyvitamin D3 Glia 22 1998 282 294 (Pubitemid 28159019)
98. H. Taniura, M. Ito, N. Sanasa, N. Kuramoto, Y. Ohno, and N. Nakamichi Chronic Vitamin D3 treatment protects against neurotoxicity by glutamate in association with upregulation of vitamin D receptor mRNA expression in cultured rat cortical neurons J Neurosci Res 83 2006 1179 1189 (Pubitemid 43668001)
99. I. Neveu, P. Naveilhan, F. Jehan, C. Baudet, D. Wion, and H.F. De Luca 1,25-dihydroxyvitamin D regulates the synthesis of nerve growth factor in primary cultures of glial cells Mol Brain Res 24 1994 70 76
100. J. Brown, J.I. Bianco, J.J. McGrath, and D.W. Eyles 1,25-dihydroxyvitamin D3 induces nerve growth factor, promotes neurite outgrowth and inhibits mitosis in embryonic rat hippocampal neurons Neurosci Lett 343 2003 139 143 (Pubitemid 36577534)
101. I. Neveu, P. Naveilhan, C. Baudet, P. Brachet, and M. Metsis 1,25-dihydroxyvitamin D3 regulates NT-3, NT-4 but not BDNF mRNA in astrocytes Neuroreport 6 1994 124 126
102. L. Almeras, D. Eyles, P. Benech, D. Laffite, C. Villard, and A. Patatian Developmental vitamin D deficiency alters brain protein expression in the adult rat: implications for neuropsychiatric disorders Proteomics 7 2007 769 780 (Pubitemid 46450654)
103. B. Sanchez, J.L. Relova, R. Gallego, I. Ben-Batalla, and R. Perez-Fernandez 1,25-dihydroxyvitamin D3 administration to 6-hydroxydopamine- lesioned rates increases GDNF and partially restores tyrosine hydroxylase expression in substantia nigra and striatum J Neurosci Res 87 2009 723 732
104. P. Naveilhan, I. Neveu, D. Wion, and P. Brachet 1,25-dihydroxyvitamin D3, an inducer of GDNF Neuroreport 7 1996 2171 2175
105. A. Cornet, C. Baudet, I. Neveu, A. Baron-van Evercooren, P. Brachet, and P. Naveilhan 1,25-hydroxyvitamin D3 regulates the expression of VDR and NGF gene in Schwann cells in vitro J Neurosci Res 53 1998 742 746 (Pubitemid 28423881)
106. D. Baas, K. Prüfer, M.E. Ittel, S. Kuchler-Bopp, G. Labourdette, and L.L. Sarliève Rat oligodendrocytes express the vitamin D3 receptor and respond to 1,25-dihydroxyvitamin D Glia 31 2000 31 59
107. H. Lassmann Pathophysiology of inflammation and tissue injury in multiple sclerosis: What are the targets for therapy J Neurol Sci 306 2011 167 169
108. Smolders J, Hupperts R, Barkhof F, Grimaldi L, Holmøy T, Killestein J, et al. Efficacy of Vitamin D3 as Add-on Therapy in Patients with Relapsing-Remitting Multiple Sclerosis Receiving Subcutaneous Interferon Beta-1a: A Planned, Phase II, Multicentre, Double-blind, Randomized, Placebo-Controlled Trial. J Neurol Sci in press, doi:10.1016/j.jns.2011.04.013.
109. J.M. Burton, S. Kimball, R. Vieth, A. Bar-Or, H.M. Dosch, and R. Cheung A phase I/II dose-escalation trial of vitamin D3 and calcium in multiple sclerosis Neurology 74 2010 1852 1859
110. 3 supplementation in multiple sclerosis PLoS One 5 2010 e15235